Orchestra BioMed Holdings, Inc. (OBIO) vs Turn Therapeutics Inc. (TTRX)
A side-by-side comparison of Orchestra BioMed Holdings, Inc. and Turn Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
OBIO
Orchestra BioMed Holdings, Inc.
$5.91HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
TTRX
Turn Therapeutics Inc.
$11.99HealthcareDelayed quote: Oct 6, 2026, 2:18 PM EDT
Total return — OBIO vs TTRX
growth of $100 · dividends reinvested · last 1yOBIO +120.9% (+120.9%/yr)TTRX +76.6% (+76.6%/yr)OBIO compounded faster over this window
OBIO TTRX
OBIO vs TTRX: by the numbers
- •TTRX is the larger company ($357M vs $354M market cap).
- •Both run net losses; TTRX's is the smaller (0.00% vs -184.60% net margin).
Metrics side by side
Valuation
| Metric | OBIO | TTRX |
|---|---|---|
| P/S ratio | 11.07 | N/A |
| P/B ratio | 18.31 | 519.97 |
Profitability
| Metric | OBIO | TTRX |
|---|---|---|
| Gross margin | 99.32% | 0.00% |
| Operating margin | -154.73% | 0.00% |
| Net margin | -184.60% | 0.00% |
| ROE | -200.64% | -1229.58% |
| ROIC | -56.73% | -84.66% |
Growth (annualized)
| Metric | OBIO | TTRX |
|---|---|---|
| Revenue CAGR (5Y) | 148.45% | N/A |
| Total return CAGR (5Y) | -9.35% | N/A |
Go deeper
Dig into the metrics
Orchestra BioMed ROETurn Therapeutics ROEOrchestra BioMed operating marginTurn Therapeutics operating marginOrchestra BioMed revenue growthTurn Therapeutics revenue growthOrchestra BioMed free cash flowTurn Therapeutics free cash flow
Orchestra BioMed & Turn Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.